ABBAX, s.r.o.Active
Key figures
Key figures
2025Balance sheet structure
Summary of annual reports2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue (net turnover) | 810 543 | 1 076 021 | 956 895 | 1 054 180 |
| Profit for the reporting year | 10 675 | 17 393 | 16 108 | 15 425 |
| Retained earnings of previous periods | 121 237 | 131 912 | 149 305 | 165 413 |
| Total assets | 284 359 | 259 253 | 274 494 | 308 547 |
| Total liabilities | 145 143 | 102 644 | 101 777 | 120 405 |
| Total equity | 139 216 | 156 609 | 172 717 | 188 142 |
| Calculated dividends | — | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Summary: ABBAX, s.r.o.
Overview
ABBAX, s.r.o. (IČO 36733741) is a limited liability company (s.r.o.). The company was incorporated in 2007 and has existed for 19 years. Registered office according to the register: Kysucké Nové Mesto. Main activity according to the Statistical Office: maloobchod s farmaceutickými výrobkami (SK NACE 4773). Size category by number of employees: 3–4 employees.
People
The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 6 640 €.
Financial results
Revenue for 2025 was 1 054 180 €, up 10,2 % on the previous year (956 895 €). From 2022 to 2025, revenue grew by an average of 9,2 % per year. Net profit for 2025 was 15 425 € (1,5 % of revenue). The company was profitable in all 4 reported years. Personnel costs for 2025 were 53 352 €. At the end of 2025 the company had total assets of 308 547 € and equity of 188 142 € (equity ratio 61,0 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 5. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.